Pricing

ATOSSA THERAPEUTICS, INC.

0 followers ·
SEATTLE WA
Atossa Therapeutics is based out of Seattle. Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to help monitor potential recurrence.Whalewisdom has at least 59 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2013-04-11. The notice included securities offered of Equity

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

ATOSSA THERAPEUTICS, INC.
107 SPRING STREET
SEATTLE WA    98104

Business Phone: 206.588.0256
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
8-K 2024-03-18
4 2024-03-14
3 2024-03-14
8-K 2024-03-12
4 2023-11-17
4 2023-11-15
4/A 2023-11-15
3 2023-11-15
10-Q 2023-11-13
8-K 2023-11-13